Subjects | CD4 counts 1 | Nadir CD4 counts 1 | CD8 counts 1 | Plasma viral load 2 | Time since infection 3 | ART | ART initiation 4 | Age 5 |
---|---|---|---|---|---|---|---|---|
CI 01 | 463 | 36 | 757 | 50 | 152 | 3TC-Efavirenz | 105 | 52 |
CI 02 | n.a. | 350 | n.a. | 50 | 94 | Kivexa-Efavirenz | 24 | 30 |
CI 03 | 616 | 486 | 330 | 40 | 186 | Truvada-Viracept | 153 | 29 |
CI 04 | 651 | 219 | 409 | 40 | 76 | Kivexa-Nevirapine | 19 | 39 |
CI 05 | 358 | 231 | 283 | 40 | 155 | Atripla | 142 | 48 |
CI 06 | 748 | 20 | 964 | 40 | 165 | Truvada-Norvir-Reyataz | 134 | 50 |
CI 07 | 517 | 223 | 259 | 40 | 82 | Kivexa-Sustiva | 39 | 35 |
CI 08 | 269 | 263 | 282 | 50 | n.a. | n.a. | n.a. | 47 |
CI 09 | 569 | 299 | 462 | 50 | 111 | Darunavir-Raltegravir | 105 | 50 |
CI 10 | 391 | 181 | 620 | 50 | 165 | Dalavirdine-Kivexa | 34 | 46 |
CI 11 | 847 | 110 | 944 | 40 | 168 | Reyataz-Kivexa | 116 | 62 |
CI 12 | 498 | 201 | 531 | 40 | 213 | Darunavir-Raltegravir-Intelence-Ritonavir | 155 | 62 |
CI 13 | 833 | 486 | 445 | 40 | 213 | Truvada-Isentress | 212 | 31 |
CI 14 | 886 | 301 | 579 | 40 | 60 | Truvada-Isentress | 15 | 54 |
CI 15 | 824 | 251 | 900 | 40 | 58 | Atripla | 11 | 31 |
CI 16 | 617 | 24 | 1,272 | 40 | 157 | Kivexa-Efavirenz | 3 | 54 |
CI 17* | 776 | 407 | 478 | 40 | 289 | Atripla | 231 | 24 |
CI 18 | 277 | 228 | 909 | 40 | 11 | Complera | 2 | 23 |
CI 19 | 459 | n.a | 545 | 40 | 215 | n.a. | n.a. | 48 |
Median | 592 | 230 | 538 | 40 | 156 | Yes | 105 | 47 |